Materials Today Bio,
Journal Year:
2024,
Volume and Issue:
28, P. 101198 - 101198
Published: Aug. 9, 2024
Bioprinting
is
a
groundbreaking
technology
that
enables
precise
distribution
of
cell-containing
bioinks
to
construct
organoid
models
accurately
reflect
the
characteristics
tumors
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(19)
Published: Feb. 13, 2024
Abstract
Engineered
biomaterial
scaffolds
are
becoming
more
prominent
in
research
laboratories
to
study
drug
efficacy
for
oncological
applications
vitro,
but
do
they
have
a
place
pharmaceutical
screening
pipelines?
The
low
of
cancer
drugs
phase
II/III
clinical
trials
suggests
that
there
critical
mechanisms
not
properly
accounted
the
pre‐clinical
evaluation
candidates.
Immune
cells
associated
with
tumor
may
account
some
these
failures
given
recent
successes
immunotherapies;
however,
few
representative
platforms
immune
context
as
traditional
2D
culture
is
typically
monocultures
and
humanized
animal
models
weakened
composition.
Biomaterials
replicate
microenvironmental
cues
provide
relevant
model
greater
vitro
complexity.
In
this
review,
authors
explore
pertinent
drive
progression
system,
discuss
how
can
be
incorporated
into
hydrogel
design
cells,
describe
progress
toward
precision
engineered
tissues.
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: May 21, 2024
Various
in
vitro
three-dimensional
(3D)
tissue
culture
models
of
human
and
diseased
skin
exist.
Nevertheless,
there
is
still
room
for
the
development
improvement
3D
bioprinted
cancer
models.
The
need
reproducible
bioprinting
methods,
cell
samples,
biomaterial
inks,
bioinks
becoming
increasingly
important.
influence
viscosity
hydrogels
on
spreading
migration
most
types
cells
well
studied.
There
are
however
limited
studies
In
this
review,
we
will
outline
importance
studying
various
cancers
by
using
We
provide
an
overview
advantages
disadvantages
technologies.
emphasize
how
relates
to
cells.
Lastly,
give
specific
JACS Au,
Journal Year:
2023,
Volume and Issue:
3(8), P. 2086 - 2106
Published: Aug. 11, 2023
Three-dimensional
(3D)
bioprinting
technologies
involving
photopolymerizable
bioinks
(PBs)
have
attracted
enormous
attention
in
recent
times
owing
to
their
ability
recreate
complex
structures
with
high
resolution,
mechanical
stability,
and
favorable
printing
conditions
that
are
suited
for
encapsulating
cells.
3D
bioprinted
tissue
constructs
PBs
can
offer
better
insights
into
the
tumor
microenvironment
platforms
drug
screening
advance
cancer
research.
These
enable
incorporation
of
physiologically
relevant
cell
densities,
tissue-mimetic
stiffness,
vascularized
channels
biochemical
gradients
models,
unlike
conventional
two-dimensional
(2D)
cultures
or
other
scaffold
fabrication
technologies.
In
this
perspective,
we
present
emerging
techniques
using
context
research,
a
specific
focus
on
efforts
recapitulate
complexity
microenvironment.
We
describe
approaches
various
PB
formulations
compatible
these
along
attempts
bioprint
models
studying
migration
metastasis,
cell–cell
interactions,
cell–extracellular
matrix
cancer.
discuss
limitations
identify
unexplored
opportunities
field
clinical
commercial
translation
TrAC Trends in Analytical Chemistry,
Journal Year:
2023,
Volume and Issue:
163, P. 117064 - 117064
Published: April 15, 2023
The
increasingly
prominent
role
played
by
precision,
equitable
and
sustainable
diagnosis,
particularly
of
prevalent
highly
heterogeneous
diseases,
based
on
the
determination
characterization
biomarkers
cellular
origin
in
liquid
biopsy,
such
as
whole
cells,
their
secretomes
exosomes
they
release,
is
unquestionable.
Electrochemical
biosensing
biosensors,
mainly
those
involving
affinity
reactions,
have
emerged
recent
years
competitive
analytical
alternatives
to
address
these
challenging
targets
versus
other
existing
strategies
terms
simplicity,
cost
compatibility
with
multiplexed
or
multi-omics
point-of-care
determinations.
This
review
article
aims
put
table
a
concise,
accurate
updated
way
fundamentals,
versatility
opportunities
provided
state-of-the-art
electrochemical
(2018–2022)
for
cellular-derived
biomarkers.
A
more
critical
personal
view
challenges
be
faced
shorter
term
where
future
research
advances
are
expected
go
also
given.
Materials Today Bio,
Journal Year:
2024,
Volume and Issue:
28, P. 101198 - 101198
Published: Aug. 9, 2024
Bioprinting
is
a
groundbreaking
technology
that
enables
precise
distribution
of
cell-containing
bioinks
to
construct
organoid
models
accurately
reflect
the
characteristics
tumors